Israel Biotech Fund Ii, L.p. - Net Worth and Insider Trading

Israel Biotech Fund Ii, L.p. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Israel Biotech Fund Ii, L.p. owns 1 companies in total, including Advaxis Inc (ADXS) .

Click here to see the complete history of Israel Biotech Fund Ii, L.p.’s form 4 insider trades.

Insider Ownership Summary of Israel Biotech Fund Ii, L.p.

Ticker Comapny Transaction Date Type of Owner
ADXS Advaxis Inc 2023-09-01 10 percent owner

Israel Biotech Fund Ii, L.p. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Israel Biotech Fund Ii, L.p. Ownership Network

Ownership Network List of Israel Biotech Fund Ii, L.p.

No Data

Ownership Network Relation of Israel Biotech Fund Ii, L.p.

Insider Network Chart

Israel Biotech Fund Ii, L.p. Owned Company Details

What does Advaxis Inc do?

Who are the key executives at Advaxis Inc?

Israel Biotech Fund Ii, L.p. is the 10 percent owner of Advaxis Inc. Other key executives at Advaxis Inc include Chief Financial Officer Roy Golan , 10 percent owner Israel Biotech Fund Gp Partners Ii, L.p. , and 10 percent owner Israel Biotech Fund Gp Partners, L.p. .

Advaxis Inc (ADXS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Advaxis Inc (ADXS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Advaxis Inc (ADXS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Advaxis Inc (ADXS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Advaxis Inc Insider Transactions

No Available Data

Israel Biotech Fund Ii, L.p. Mailing Address

Above is the net worth, insider trading, and ownership report for Israel Biotech Fund Ii, L.p.. You might contact Israel Biotech Fund Ii, L.p. via mailing address: 4 Oppenheimer St., Rehovot L3 7670104.

Discussions on Israel Biotech Fund Ii, L.p.

No discussions yet.